Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods

被引:140
|
作者
Dunn, G
Maracy, M
Tomenson, B
机构
[1] Univ Manchester, Biostat Grp, Div Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England
[2] Univ Isfahan, Fac Med, Esfahan, Iran
[3] Univ Manchester, Sch Med, Div Psychiat, Manchester M13 9PT, Lancs, England
关键词
D O I
10.1191/0962280205sm403oa
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Perfectly implemented randomized clinical trials, particularly of complex interventions, are extremely rare. Almost always they are characterized by imperfect adherence to the randomly allocated treatment and variable amounts of missing outcome data. Here we start by describing a wide variety of examples and then introduce instrumental variable methods for the analysis of such trials. We concentrate mainly on situations in which compliance is all or nothing ( either the patient receives the allocated treatment or they do not - in the latter case they may receive no treatment or a treatment other than the one allocated). The main purpose of the review is to illustrate the use of latent class ( finite mixture) models, using maximum likelihood, for complier-average causal effect estimation under varying assumptions concerning the mechanism of the missing outcome data.
引用
收藏
页码:369 / 395
页数:27
相关论文
共 50 条
  • [1] Noncompliance in Prospective Retina Clinical Trials: Analysis of Factors Predicting Loss to Follow-up
    Zhou, Brenda
    Mitchell, Travis C.
    Rusakevich, Alexander M.
    Brown, David M.
    Wykoff, Charles C.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 210 : 86 - 96
  • [2] A Comparison of Methods for Estimating the Causal Effect of a Treatment in Randomized Clinical Trials Subject to Noncompliance
    Little, Roderick J.
    Long, Qi
    Lin, Xihong
    [J]. BIOMETRICS, 2009, 65 (02) : 640 - 649
  • [3] Estimating the efficacy of receiving treatment in randomized clinical trials with noncompliance
    Marcus S.M.
    Gibbons R.D.
    [J]. Health Services and Outcomes Research Methodology, 2001, 2 (3-4) : 247 - 258
  • [4] Multiple Imputation Methods for Treatment Noncompliance and Nonresponse in Randomized Clinical Trials
    Taylor, L.
    Zhou, X. H.
    [J]. BIOMETRICS, 2009, 65 (01) : 88 - 95
  • [5] Loss to follow-up in clinical trials - Implications and prevention
    Bakshi, Satvinder Singh
    Kalidoss, Vinoth Kumar
    [J]. CLINICAL CANCER INVESTIGATION JOURNAL, 2021, 10 (05): : 265 - 266
  • [6] Loss to follow-up in orthopaedic clinical trials: a systematic review
    Jeremy S. Somerson
    Katherine C. Bartush
    Jeffrey B. Shroff
    Mohit Bhandari
    Boris A. Zelle
    [J]. International Orthopaedics, 2016, 40 : 2213 - 2219
  • [7] Loss to follow-up in orthopaedic clinical trials: a systematic review
    Somerson, Jeremy S.
    Bartush, Katherine C.
    Shroff, Jeffrey B.
    Bhandari, Mohit
    Zelle, Boris A.
    [J]. INTERNATIONAL ORTHOPAEDICS, 2016, 40 (11) : 2213 - 2219
  • [8] Bias and Loss to Follow-Up in Cardiovascular Randomized Trials: A Systematic Review
    Fong, Lucas Chun Wah
    Ford, Thomas J.
    Costa, Bruno R.
    Juni, Peter
    Berry, Colin
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (14):
  • [9] The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials
    Hedden, Sarra L.
    Woolson, Robert F.
    Carter, Rickey E.
    Palesch, Yuko
    Upadhyaya, Himanshu P.
    Malcolm, Robert J.
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2009, 37 (01) : 54 - 63
  • [10] Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study
    Latimer, Nicholas R.
    Abrams, Keith R.
    Lambert, Paul C.
    Morden, James P.
    Crowther, Michael J.
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2018, 27 (03) : 765 - 784